{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:12:05Z","timestamp":1778778725272,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024215","name":"ICMR - National Institute of Virology","doi-asserted-by":"publisher","award":["NARI\/SAC\/2022-23\/2266"],"award-info":[{"award-number":["NARI\/SAC\/2022-23\/2266"]}],"id":[{"id":"10.13039\/501100024215","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejpb.2025.114963","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T17:29:37Z","timestamp":1765560577000},"page":"114963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Co-delivery of dolutegravir and carbon-nanoparticles using niosomal platform for enhanced anti-HIV and pharmacokinetic activity"],"prefix":"10.1016","volume":"219","author":[{"given":"Kaushiki","family":"Ash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7569-4815","authenticated-orcid":false,"given":"R","family":"Harshithkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7463-8077","authenticated-orcid":false,"given":"Madhuri","family":"Chandane-Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0612-2258","authenticated-orcid":false,"given":"Anupam","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyajit","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-6021","authenticated-orcid":false,"given":"Abhimanyu","family":"Dev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114963_b0005","unstructured":"World Health, O., HIV drug resistance: brief report 2024. 2024: World Health Organization."},{"key":"10.1016\/j.ejpb.2025.114963_b0010","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.2147\/IJN.S25871","article-title":"Anti-HIV-1 nanotherapeutics: promises and challenges for the future","volume":"7","author":"Mahajan","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114963_b0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1570162X11311020002","article-title":"Epidemiology of HIV infection in women and children: a global perspective","volume":"11","author":"Shetty","year":"2013","journal-title":"Curr. HIV Res."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jiac.2016.10.002","article-title":"Current status of HIV\/AIDS in the ART era","volume":"23","author":"Yoshimura","year":"2017","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ejpb.2025.114963_b0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/B978-0-323-91814-5.00023-4","article-title":"Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat","volume":"Elseveir","author":"Sued","year":"2023","journal-title":"Viral Infections and Antiviral Therapies."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114963_b0030","first-page":"1","article-title":"Nanotechnology approaches for antiretroviral drugs delivery","volume":"1","author":"Iannazzo","year":"2015","journal-title":"J Aids Hiv Infec"},{"key":"10.1016\/j.ejpb.2025.114963_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122226","article-title":"Anti-CD4 antibody and dendrimeric peptide based targeted nano-liposomal dual drug formulation for the treatment of HIV infection","volume":"334","author":"Mutalik","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114963_b0045","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s13346-023-01492-8","article-title":"Antiretroviral action of Rosemary oil-based atazanavir formulation and the role of self-nanoemulsifying drug delivery system in the management of HIV-1 infection","volume":"14","author":"Kumar","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114963_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-01995-y","article-title":"Enhanced solubility and bioavailability of dolutegravir by solid dispersion method: In vitro and in vivo evaluation\u2014A potential approach for HIV therapy","volume":"22","author":"Chaudhary","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"15","key":"10.1016\/j.ejpb.2025.114963_b0055","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/jssc.202100152","article-title":"Box\u2013Behnken design aided optimization and validation of developed reverse phase HPLC analytical method for simultaneous quantification of dolutegravir sodium and lamivudine co\u2010loaded in nano\u2010liposomes","volume":"44","author":"Mutalik","year":"2021","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.ejpb.2025.114963_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105137","article-title":"Investigation of drug-polymer miscibility, biorelevant dissolution, and bioavailability improvement of Dolutegravir-polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer solid dispersions","volume":"142","author":"Lakshman","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114963_b0065","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jddst.2019.06.014","article-title":"Intranasal dolutegravir sodium loaded nanoparticles of hydroxypropyl-beta-cyclodextrin for brain delivery in Neuro-AIDS","volume":"52","author":"Belgamwar","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114963_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5101\/nbe.v9i3.p242-248","article-title":"Formulation and evaluation of etoricoxib niosomes by thin film hydration technique and ether injection method","volume":"9","author":"Ravalika","year":"2017","journal-title":"Nano Biomed Eng"},{"key":"10.1016\/j.ejpb.2025.114963_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.745099","article-title":"Streptomycin sulfate\u2013loaded niosomes enables increased antimicrobial and anti-biofilm activities","volume":"9","author":"Mansouri","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"9","key":"10.1016\/j.ejpb.2025.114963_b0080","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3109\/03639045.2011.560605","article-title":"Niosomal encapsulation of the antitubercular drug, pyrazinamide","volume":"37","author":"El-Ridy","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/08982104.2012.727422","article-title":"Development of a novel vesicular system using a binary mixture of sorbitan monostearate and polyethylene glycol fatty acid esters for rectal delivery of rutin","volume":"23","author":"Kamel","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2025.114963_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106052","article-title":"Functionalized niosomes as a smart delivery device in cancer and fungal infection","volume":"168","author":"Aparajay","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/08982104.2016.1254242","article-title":"Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach","volume":"28","author":"Sylvester","year":"2018","journal-title":"J. Liposome Res."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114963_b0100","doi-asserted-by":"crossref","first-page":"798","DOI":"10.31925\/farmacia.2018.5.9","article-title":"Application of the quality by design concept in the development of quercetin-loaded polymeric nanoparticles","volume":"66","author":"Tefas","year":"2018","journal-title":"Farmacia"},{"key":"10.1016\/j.ejpb.2025.114963_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2019.03.017","article-title":"Development of liposomes using formulation by design: Basics to recent advances","volume":"224","author":"Jain","year":"2019","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejpb.2025.114963_b0110","article-title":"Folic acid conjugated capecitabine capped green synthesized fluorescent carbon dots as a targeted nano-delivery system for colorectal cancer","volume":"33","author":"Paliwal","year":"2022","journal-title":"Mater. Today Commun."},{"issue":"41","key":"10.1016\/j.ejpb.2025.114963_b0115","doi-asserted-by":"crossref","first-page":"25354","DOI":"10.1039\/D1RA04718C","article-title":"Green synthesis of carbon dots and their applications","volume":"11","author":"Chahal","year":"2021","journal-title":"RSC Adv."},{"issue":"95","key":"10.1016\/j.ejpb.2025.114963_b0120","doi-asserted-by":"crossref","first-page":"92996","DOI":"10.1039\/C6RA21062G","article-title":"Design of boronic acid-attributed carbon dots on inhibits HIV-1 entry","volume":"6","author":"Fahmi","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2025.114963_b0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.colsurfb.2017.07.030","article-title":"Doxorubicin-loaded environmentally friendly carbon dots as a novel drug delivery system for nucleus targeted cancer therapy","volume":"159","author":"Yuan","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"12","key":"10.1016\/j.ejpb.2025.114963_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115323","article-title":"Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model","volume":"9","author":"Pasetto","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejpb.2025.114963_b0135","first-page":"463","article-title":"In vitro anti-HIV-1 activities of kaempferol and kaempferol-7-O-glucoside isolated from Securigera securidaca","volume":"9","author":"Behbahani","year":"2014","journal-title":"Research in Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2025.114963_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12981-017-0183-6","article-title":"The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro","volume":"14","author":"Ortega","year":"2017","journal-title":"AIDS Res. Ther."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114963_b0145","first-page":"18","article-title":"Buchanania lanzan spreng: A veritable storehouse of phytomedicines","volume":"8","author":"Banerjee","year":"2015","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114963_b0150","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1016\/j.msec.2013.03.018","article-title":"Green synthesis of biocompatible carbon dots using aqueous extract of Trapa bispinosa peel","volume":"33","author":"Mewada","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2025.114963_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2021.02.015","article-title":"Design, development and in-vitro\/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer\u2019s disease","volume":"163","author":"Kulkarni","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114963_b0160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5101\/nbe.v10i2.p174-180","article-title":"Preparation and characterization of naproxen loaded niosomes by ether injection method","volume":"10","author":"Sailaja","year":"2018","journal-title":"Nano Biomed. Eng"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114963_b0165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1366\/000370210791114301","article-title":"A chemometric method for correcting Fourier transform infrared spectra of biomaterials for interference from water in KBr discs","volume":"64","author":"Gordon","year":"2010","journal-title":"Appl. Spectrosc."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0170","first-page":"28","article-title":"Development and evaluation of eberconazole-loaded niosomes","volume":"8","author":"Aparajay","year":"2021","journal-title":"Chemistry Proceedings"},{"key":"10.1016\/j.ejpb.2025.114963_b0175","first-page":"81","article-title":"X-ray diffraction (XRD) techniques for materials characterization. Materials characterization using nondestructive evaluation (NDE)","volume":"Elsevier","author":"Epp","year":"2016","journal-title":"Methods"},{"issue":"8","key":"10.1016\/j.ejpb.2025.114963_b0180","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1021\/mp400154a","article-title":"Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method","volume":"10","author":"Modi","year":"2013","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114963_b0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/1570162X16666180924101650","article-title":"Formulation and in-vivo evaluation of novel topical gel of lopinavir for targeting HIV","volume":"16","author":"Ansari","year":"2018","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ejpb.2025.114963_b0190","doi-asserted-by":"crossref","unstructured":"Tyagi, P. and M. Tyagi, An overview of the mechanisms of HIV-1 infection, latency, pathogenesis, and eradication strategies from the CNS. HIV-Associated Neurocognitive Disorders, 202424: p. 1-22.","DOI":"10.1016\/B978-0-323-99744-7.00007-9"},{"key":"10.1016\/j.ejpb.2025.114963_b0195","doi-asserted-by":"crossref","unstructured":"Gaikwad, S.Y., P. Phatak, and A. Mukherjee, Cutting edge strategies for screening of novel anti-HIV drug candidates against HIV infection: A concise overview of cell based assays. Heliyon, 2023. 9(5): p. 28-36.","DOI":"10.1016\/j.heliyon.2023.e16027"},{"issue":"10","key":"10.1016\/j.ejpb.2025.114963_b0200","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/antiox11101942","article-title":"Elucidation of antiviral and antioxidant potential of C-phycocyanin against HIV-1 infection through in silico and in vitro approaches","volume":"11","author":"Jadaun","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12985-023-02130-y","article-title":"Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection","volume":"20","author":"Jadaun","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.ejpb.2025.114963_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejps.2018.06.025","article-title":"Liposils: An effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silica","volume":"122","author":"Ingle","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114963_b0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAI.0000000000000830","article-title":"The safety and immunogenicity of an interleukin-12\u2013enhanced multiantigen DNA vaccine delivered by electroporation for the treatment of HIV-1 infection","volume":"71","author":"Jacobson","year":"2016","journal-title":"JAIDS J. Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.ejpb.2025.114963_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120889","article-title":"Ultra-long acting prodrug of dolutegravir and delivery system\u2013Physicochemical, pharmacokinetic and formulation characterizations","volume":"607","author":"Khuroo","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114963_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2019.118006","article-title":"FTIR investigation of the secondary structure of type I collagen: New insight into the amide III band","volume":"229","author":"Stani","year":"2020","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejpb.2025.114963_b0230","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ijbiomac.2018.05.010","article-title":"In vitro and In vivo characterization of quercetin loaded multiphase hydrogel for wound healing application","volume":"115","author":"Jangde","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2025.114963_b0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijbiomac.2017.07.006","article-title":"Synthesis and characterization of chitosan-PVP-nanocellulose composites for in-vitro wound dressing application","volume":"105","author":"Poonguzhali","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114963_b0240","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3923\/pjbs.2006.1181.1191","article-title":"Liposome as a carrier for advanced drug delivery","volume":"9","author":"Shaheen","year":"2006","journal-title":"Pak. J. Biol. Sci."},{"key":"10.1016\/j.ejpb.2025.114963_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-021-05076-6","article-title":"Carbon dots for virus detection and therapy","volume":"188","author":"Belza","year":"2021","journal-title":"Microchim. Acta"},{"issue":"6","key":"10.1016\/j.ejpb.2025.114963_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13201-020-01213-3","article-title":"Optimization using central composite design (CCD) of response surface methodology (RSM) for biosorption of hexavalent chromium from aqueous media","volume":"10","author":"Bayuo","year":"2020","journal-title":"Appl Water Sci"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1166\/jpsp.2015.1042","article-title":"Pioglitazone loaded vesicular carriers for anti-diabetic activity: development and optimization as per central composite design","volume":"2","author":"Haider","year":"2015","journal-title":"J. Pharmaceutical Sci. Pharmacology"},{"issue":"2","key":"10.1016\/j.ejpb.2025.114963_b0265","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2015.06.026","article-title":"Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach","volume":"94","author":"Soema","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0270","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.msec.2016.07.043","article-title":"Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis","volume":"69","author":"Moghddam","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"issue":"2","key":"10.1016\/j.ejpb.2025.114963_b0275","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jfoodeng.2013.02.020","article-title":"Preparation and characterization of niosomes containing resveratrol","volume":"117","author":"Pando","year":"2013","journal-title":"J. Food Eng."},{"issue":"9","key":"10.1016\/j.ejpb.2025.114963_b0280","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2174\/1567201815666180619105419","article-title":"Implementing central composite design for developing transdermal diacerein-loaded niosomes: ex vivo permeation and in vivo deposition","volume":"15","author":"Aziz","year":"2018","journal-title":"Curr. Drug Deliv."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114963_b0285","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","article-title":"Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes","volume":"361","author":"Mokhtar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114963_b0290","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s13346-018-0499-3","article-title":"Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer","volume":"8","author":"Salem","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114963_b0295","first-page":"6","article-title":"Suspension stability; why particle size, zeta potential and rheology are important","volume":"20","author":"Larsson","year":"2012","journal-title":"Annu. Trans. Nord. Rheol. Soc"},{"issue":"9","key":"10.1016\/j.ejpb.2025.114963_b0300","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1080\/03639045.2017.1318907","article-title":"Optimization of methotrexate loaded niosomes by Box\u2013Behnken design: An understanding of solvent effect and formulation variability","volume":"43","author":"Zidan","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2025.114963_b0305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0927-7757(00)00560-4","article-title":"Microcalorimetric and shear studies on the effects of cholesterol on the physical stability of lipid vesicles","volume":"172","author":"Liu","year":"2000","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.ejpb.2025.114963_b0310","first-page":"1","article-title":"Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies\/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I\/II randomized controlled clinical trial","volume":"13","author":"Loret","year":"2016","journal-title":"Retrovirology"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114963_b0315","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/pharmaceutics11040184","article-title":"Design of poly (lactic-co-glycolic acid)(PLGA) nanoparticles for vaginal co-delivery of griffithsin and dapivirine and their synergistic effect for HIV prophylaxis","volume":"11","author":"Yang","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0320","article-title":"Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement","volume":"2014","author":"Kamboj","year":"2014","journal-title":"Scientific World Journal"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114963_b0325","article-title":"Human, cattle and goat blood as substitutes for sheep blood in blood-supplemented culture media. Sri Lankan","volume":"8","author":"Dilrukshi","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114963_b0330","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijpharm.2017.02.024","article-title":"In situ hybrid nano drug delivery system (IHN-DDS) of antiretroviral drug for simultaneous targeting to multiple viral reservoirs: An in vivo proof of concept","volume":"521","author":"Jindal","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114963_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105916","article-title":"Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: An in-vivo proof of concept","volume":"164","author":"Rojekar","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114963_b0340","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1208\/s12249-022-02377-8","article-title":"Mannose-anchored nano-selenium loaded nanostructured lipid carriers of etravirine for delivery to HIV reservoirs","volume":"23","author":"Rojekar","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2025.114963_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119095","article-title":"Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: Effect on ocular disposition","volume":"577","author":"Pai","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114963_b0350","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1211\/jpp.61.11.0007","article-title":"Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers","volume":"61","author":"Li","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114963_b0355","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.talanta.2018.01.069","article-title":"Glycosylated liposomes loading carbon dots for targeted recognition to HepG2 cells","volume":"182","author":"Guan","year":"2018","journal-title":"Talanta"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:27:29Z","timestamp":1778776049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125003418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":70,"alternative-id":["S0939641125003418"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114963","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-delivery of dolutegravir and carbon-nanoparticles using niosomal platform for enhanced anti-HIV and pharmacokinetic activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114963"}}